Picture of Science logo

SAG Science News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsConservativeSmall CapHigh Flyer

REG - Science Group PLC Ricardo PLC - Shareholding in Ricardo plc

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250311:nRSK1720Aa&default-theme=true

RNS Number : 1720A  Science Group PLC  11 March 2025

 

11 March 2025

 

Science Group plc

(the "Group" or "Science Group")

 

Shareholding in Ricardo plc

 

Science Group has further increased its shareholding in Ricardo plc
("Ricardo") to 8,824,994 shares, equivalent to approximately 14.18% of the
voting rights. Science Group may or may not increase its shareholding in
Ricardo.

 

The strategic investment in Ricardo represents a substantial transaction under
rule 12 of the AIM Rules for Companies ("AIM Rules") and the following
disclosure is made in accordance with Schedule Four of the AIM Rules. Ricardo
reported profit before tax for the year ended 30 June 2024 of £4.3 million
and gross assets at 31 December 2024 of £457.7 million.

 

 

 

- Ends -

 For further information:

Science Group plc
 Martyn Ratcliffe, Executive Chair                                               Tel: +44 (0) 1223 875 200
 Jon Brett, Finance Director                                                     www.sciencegroup.com
                                         (https://protect.checkpoint.com/v2/r06/___http:/www.sciencegroup.com___.ZXV3MjpuZXh0MTU6YzpvOjU0ZGI5YzMxZTIyYWRjYjNiNDllZDg0YzAwYjdlYTg0Ojc6ODkyNTpiMmM0ZGYxMGZmNjg5OGUzNTZjZDliYzcxZTZjOWMxY2YxNDJiNjliNzg1Y2E2ZjdiNWUyNWIxMTE3NTdkMjgzOnA6VDpU)

 Canaccord Genuity Limited (Nominated Adviser and Joint Broker)
 Simon Bridges, Andrew Potts                                                     Tel: +44 (0) 20 7523 8000
 MHP
 Reg Hoare                                                                       Tel: +44 (0) 7831 406117

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFIFFTVEILLIE

Recent news on Science

See all news